January is a time of reflection, fresh beginnings, and new opportunities. We are doing the same thing here at Psychiatric Times.
FROM THE CHAIRMAN OF MJH LIFE SCIENCES
January is a time of reflection, fresh beginnings, and new opportunities, and a time of new year resolutions. The slate is wiped clean, and we all try to be the best version of ourselves.
We are doing the same thing here at Psychiatric Times. We are looking back at where we have been, and we are looking ahead to where we want to be. On our cover, Dr Allen Frances shares potential new year resolutions for policy makers, addressing the issues in our mental health care system that he thinks can be changed for the better. And, in noting the great potential for this upcoming new decade, Editor in Chief Dr John Miller shares his wish list of advances. With some perseverance, perhaps we will be looking back 10 years from now feeling satisfied that the field has addressed some, if not all, of those items.
Psychiatric Times’ continued resolution is to provide you with clinically useful information to support you. With that in mind, Drs Pojen Deng and Anusha Yeshokumar shed some light on autoimmune encephalitis, an emerging and unique clinical entity that causes severe neuropsychiatric symptoms. In our Mood Disorders Special Report, you will find strategies for integrating psychopharmacology and psychotherapy and ways to overcome challenges in pediatric bipolar disorder. You also can earn CME credit while exploring how to overcome treatment resistant depression in older patients. And, you will find many more informative clinical pieces with up-to-date guidance and tips on our website at www.psychiatrictimes.com.
No matter what the challenge, Psychiatric Times looks forward to being your go-to resource for clinical updates you can use and important information impacting the field in 2020 and beyond!
Mr Hennessy is Chairman and Founder, MJH Life Sciences, Parent Company of Psychiatric Times.